Synthetic oligonucleotides as modulators of inflammation

Journal of Leukocyte Biology

Volumn 84, Issue 4, 2008, Pages 958-964

  Klinman, Dennis ^a   Shirota, Hidekazu ^a   Tross, Debra ^a   Sato, Takashi ^a   Klaschik, Sven ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; CpG; ODN; Suppressive; Therapy

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOLOGICAL ADJUVANT;

ALLERGIC ASTHMA; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CONFERENCE PAPER; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GLIOBLASTOMA; HOST SUSCEPTIBILITY; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION SENSITIVITY; KIDNEY CARCINOMA; LISTERIOSIS; MELANOMA; MOLECULAR MIMICRY; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; THERAPY EFFECT; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AUTOIMMUNE DISEASES; CELL SURVIVAL; DINUCLEOSIDE PHOSPHATES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; OLIGODEOXYRIBONUCLEOTIDES; SHOCK, SEPTIC;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 48849089879     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107775     Document Type: Conference Paper

References (87)

1. Krieg, A. M. (1995) CpG DNA: a pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol. 15, 284-292.
2. Zeuner, R. A., Verthelyi, D., Gursel, M., Ishii, K. J., Klinman, D. M. (2003) Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis. Arthritis Rheum. 48, 1701-1707.
3. Sparwasser, T., Meithke, T., Lipford, G., Borschert, K., Hicker, H., Heeg, K., Wagner, H. (1997) Bacterial DNA causes septic shock. Nature 386, 336-338.
4. Cowdery, J. S., Chace, J. H., Yi, A-K., Krieg, A. M. (1996) Bacterial DNA induces NK cells to produce IFNγ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156, 4570-4575.
5. Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R., Aguzzi, A. (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 10, 187-192.
6. Deng, G. M., Nilsson, I. M., Verdrengh, M., Collins, L. V., Tarkowski, A. (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5, 702-705.
7. Gursel, I., Gursel, M., Yamada, H., Ishii, K. J., Takeshita, F., Klinman, D. M. (2003) Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J. Immunol. 171, 1393-1400.
8. Zeuner, R. A., Ishii, K. J., Lizak, M. J., Gursel, I., Yamada, H., Klinman, D. M., Verthelyi, D. (2002) Reduction of GpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum. 46, 2219-2224.
9. Yamada, H., Gursel, I., Takeshita, F., Conover, J., Ishii, K. J., Gursel, M., Takeshita, S., Klinman, D. M. (2002) Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 169, 5590-5594.
10. Yamamoto, S., Yamamoto, T., Tokunaga, T. (2000) Oligodeoxyribonucleotides with 5′-ACGT-3′ or 5′-TCGA-3′ sequence induce production of interferon. In: Immunobiology of Bacterial DNA (Wagner, H., ed.) Springer, New York. pp. 23-40.
11. Yamamoto, S., Yamamoto, T., Katoaka, T., Kuramoto, E., Yano, O., Tokunaga, T. (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148, 4072-4076.
12. Krieg, A. M., Yi, A., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-548.
13. Klinman, D. M., Yi, A., Beaucage, S. L., Conover, J., Krieg, A. M. (1996) CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNγ. Proc. Natl. Acad. Sci. USA 93, 2879-2883.
14. Halpern, M. D., Pisetsky, D. S. (1995) In vitro inhibition of murine IFN γ production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology 29, 47-52.
15. Pisetsky D. S., Reich, C. F. (2000) Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin. Immunol. 96, 198-204.
16. Zhu, F. G., Reich, C. F., Pisetsky, D. S. (2002) Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides. J. Leukoc. Biol. 71, 686-694.
17. Zhu, F. G., Reich, C. F., Pisetsky, D. S. (2002) Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides. J. Leukoc. Biol. 72, 1154-1163.
18. Gursel, M., Verthelyi, D., Gursel, I., Ishii, K. J., Klinman, D. M. (2002) Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotides. J. Leukoc. Biol. 71, 813-820.
19. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G. (2002) Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
20. Hemmi, H., Takeuchi, O., Kawai, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
21. Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K., Takeshita, S., Gursel, M., Klinman, D. M. (2001) Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167, 3555-3558.
22. Sun, S., Zhang, X., Tough, D. F., Sprent, J. (1998) Type I interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 188, 2335-2342.
23. Stacey, K. J., Sweet, M. J., Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116-2120.
24. Ballas, Z. K., Rasmussen, W. L., Krieg, A. M. (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1847.
25. Halpern, M. D., Kurlander, R. J., Pisetsky, D. S. (1996) Bacterial DNA induces murine interferon-γ production by stimulation of IL-12 and tumor necrosis factor-α. Cell. Immunol. 167, 72-78.
26. Ishii, K. J., Takeshita, F., Gursel, I., Gursel, M., Conover, J., Nussenzweig, A., Klinman, D. M. (2002) Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196, 269-274.
27. Rankin, R., Pontarollo, R., Ioannou, X., Krieg, A. M., Hecker, R., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2001) CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11, 333-340.
28. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., Raz, E. (1997) Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants. Nat. Med. 3, 849-854.
29. Broide, D. H., Stachnick, G., Castaneda, D., Nayar, J., Miller, M., Cho, J. Y., Roman, M., Zubeldia, J., Hayashi, T., Raz, E., Hyashi, T. (2001) Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J. Clin. Immunol. 21, 175-182.
30. Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., Klinman, D. M. (2001) Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166, 2372-2377.
31. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., Hartmann, G. (2001) Identification of CpG oligonucleotide sequences with high induction of IFNα/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163.
32. Bauer, S., Kirschning, C. J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., Lipford, G. B. (2001) Human TLR9 confers responsiveness to bacterial DNA via species -specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98, 9237-9242.
33. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., Liu, Y. J. (2001) Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
34. Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., Hartmann, G. (2001) Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037.
35. Bauer, M., Redecke, V., Ellwart, J. W., Sherer, B., Kremer, J. P., Wagner, H., Lipford, G. B. (2001) Bacterial CpG DNA triggers activation and maturation of human CD11c(-), CD123(+) dendritic cells. J. Immunol. 166, 5000-5007.
36. Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., Endres, S. (2003) Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33, 1633-1641.
37. Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L., Van Nest, G. (2003) Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73, 781-792.
38. Hartmann, G., Krieg, A. M. (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164, 944-952.
39. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., Taniguchi, T. (2005) Spatiotemporal regulation of MyD88-IRF-7 signaling for robust type-I interferon induction. Nature 434, 1035-1040.
40. Gursel, M., Gursel, I., Mostowski, H. S., Klinman, D. M. (2006) CXCL16 influences the nature and specificity of CpG-induced immune activation. J. Immunol. 177, 1575-1580.
41. Hartmann, G., Weeratna, R. D., Ballas, Z. K., Payette, P., Blackwell, S., Suparto, I., Rasmussen, W. L., Waldshmidt, M., Sajuthi, D., Purcell, R. H., Davis, H. L., Krieg, A. M. (2000) Delineation of a CpG phosphorothioate oligodeoxinucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164, 1617-1624.
42. Stunz, L. L., Lenert, P., Peckham, D., Yi, A. K., Haxhinasto, S., Chang, M., Krieg, A. M., Ashman, R. F. (2002) Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 32, 1212-1222.
43. Duramad, O., Fearon, K. L., Chang, B., Chan, J. H., Gregorio, J., Coffman, R. L., Barrat, F. J. (2005) Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J. Immunol. 174, 5193-5200.
44. Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love, L., Yang, L., Yi, A., Short, D., Davis, H. L. (1998) Sequence motifs in adenoviral DNA block immune activation by stimuatory CpG motifs. Proc. Natl. Acad. Sci. USA 95, 12631-12636.
45. Klinman, D. M., Gursel, I., Klaschik, S., Dong, L., Currie, D., Shirota, H. (2005) Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifs. Ann. N. Y. Acad. Sci. 1058, 87-95.
46. Lenert, P., Stunz, L., Yi, A. K., Krieg, A. M., Ashman, R. F. (2001) CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-B activation. Antisense Nucleic Acid Drug Dev. 11, 247-256.
47. Shirota, H., Gursel, I., Gursel, M., Klinman, D. M. (2005) Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock. J. Immunol. 174, 4579-4583.
48. Hartmann, E., Wollenberg, B., Rothenfusser, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., Hartmann, G. (2003) Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 63, 6478-6487.
49. Heckelsmiller, K., Rall, K., Beck, S., Schlamp, A., Seiderer, J., Jahrsdorfer, B., Krug, A., Rothenfusser, S., Endres, S., Hartmann, G. (2002) Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model. J. Immunol. 169, 3892-3899.
50. Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., Hammerling, G. J. (2001) NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J. Immunol. 167, 5247-5253.
51. Carpentier, A. F., Chen, L., Maltonti, F., Delattre, J. Y. (1999) Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. Cancer Res. 59, 5429-5432.
52. Baines, J., Celis, E. (2003) Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides. Clin. Cancer Res. 9, 2693-2700.
53. Speiser, D. E., Lienard, D., Rufer, N., Rubio-Godoy, V., Rimoldi, D., Lejeune, F., Krieg, A. M., Cerottini, J. C., Romero, P. (2005) Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J. Clin. Invest. 115, 739-746.
54. Krieg, A. M. (2004) Antitumor applications of stimulating Toll-like receptor 9 with CpG oligodeoxynucleotides. Curr. Oncol. Rep. 6, 88-95.
55. Weigel, B. J., Rodeberg, D. A., Krieg, A. M., Blazar, B. R. (2003) CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. Clin. Cancer Res. 9, 3105-3114.
56. Ishii, K. J., Gursel, I., Gursel, M., Klinman, D. M. (2004) Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. Curr. Opin. Mol. Ther. 6, 166-174.
57. Krieg, A. M. (2007) Development of TLR9 agonists for cancer therapy. J. Clin. Invest. 117, 1184-1194.
58. Ishii, K. J., Kawakami, K., Gursel, I., Conover, J., Joshi, B. H., Klinman, D. M., Puri, R. K. (2003) Antitumor therapy with bacterial DNA and toxin: complete regression of established tumor induced by liposomal CpG oligodeoxynucleotides plus interleukin-13 cytotoxin. Clin. Cancer Res. 9, 6516-6522.
59. Klinman, D. M. (2004) Use of CpG oligodeoxynucleotides as immunoprotective agents. Expert Opin. Biol. Ther. 4, 937-946.
60. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., Klinman, D. M. (1999) Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162, 2291-2298.
61. Ishii, K. J., Ito, S., Conover, J., Tamura, T., Hemmi, H., Ozato, K., Akira, S., Klinman, D. M. (2005) CpG-activated Thy1.2+ dendritic cells protect against lethal Listeria monocytogenes infection. Eur. J. Immunol. 35, 2397-2405.
62. Coyle, A. J., Wagner, K., Bertrand, C., Tsuyuki, S., Bews, J., Heusser, C. (1996) Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183, 1303-1310.
63. Sur, S., Lam, F., Bouchard, A., Sigounas, A., Holbert, D., Metzger, W. J. (1996) Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157, 4173-4180.
64. Sur, S., Wild, J. S., Choudhury, B. K., Alam, R., Sur, N., Klinman, D. M. (1999) Long-term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162, 6284-6291.
65. Gauvreau, G. M., Hessel, E. M., Boulet, L. P., Coffman, R. L., O'Byrne, P. M. (2006) Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am. J. Respir. Crit. Care Med. 174, 15-20.
66. Creticos, P. S., Schroeder, J. T., Hamilton, R. G., Balcer-Whaley, S. L., Khattignavong, A. P., Lindblad, R., Li, H., Coffman, R., Seyfert, V., Eiden, J. J., Broide, D. (2006) Immunotherapy with a ragweed-Toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355, 1445-1455.
67. Moldoveanu, Z., Love-Homan, L., Huang, W. Q., Krieg, A. M. (1998) CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16, 1216-1224.
68. McCluskie, M. J., Davis, H. L. (1998) CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161, 4463-4466.
69. Branda, R. F., Moore, A. L., Lafayette, A. R., Mathews, L., Hong, R., Zon, G., Brown, T., McCormack, J. J. (1996) Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J. Lab. Clin. Med. 128, 329-338.
70. Krieg, A. M. (2007) Antiinfective applications of Toll-like receptor 9 agonists. Proc. Am. Thorac. Soc. 4, 289-294.
71. Klinman, D. M., Xie, H., Ivins, B. E. (2006) CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine. Ann. N. Y. Acad. Sci. 1082, 137-150.
72. Xie, H., Gursel, I., Ivins, B. E., Singh, M., O'Hagan, D. T., Ulmer, J. B., Klinman, D. M. (2005) CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect. Immun. 73, 828-833.
73. Klinman, D. M., Xie, H., Little, S. F., Currie, D., Ivins, B. E. (2004) CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques. Vaccine 22, 2881-2886.
74. Rynkiewicz, D., Rathkopf, M., Ransom, J., Sim, I., Giri, L., Quinn, J., Waytes, T., Al-Adhami, M., Johnson, W., Nielsen, C. (2005) Marked Enhancement of Antibody Response to Anthrax Vaccine Adsorbed with CpG 7909 in Healthy Volunteers. Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract LB-25.
75. Braun, J., Kingsley, G., van der, H. D., Sieper, J. (2000) On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J. Rheumatol. 27, 2185-2192.
76. Sieper, J., Braun, J., Kingsley, G. H. (2000) Report on the Fourth International Workshop on Reactive Arthritis. Arthritis Rheum. 43, 720-734.
77. Myers, L. K., Rosloniec, E. F., Cremer, M. A., Kang, A. H. (1997) Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61, 1861-1878.
78. Dong, L., Ito, S., Ishii, K. J., Klinman, D. M. (2004) Suppressive oligodeoxynucleotides protect against the development of collagen-induced arthritis in mice. Arthritis Rheum. 50, 1686-1689.
79. Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Briere, F., Trinchieri, G. (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150.
80. Klinman, D. M., Steinberg, A. D. (1995) Inquiry into murine and human lupus. Immunol. Rev. 144, 157-193.
81. Hahn, B. H. (1998) Antibodies to DNA. N. Engl. J. Med. 338, 1359-1368.
82. Lambert, P. H., Dixon, F. J. (1968) Pathogenesis of the glomerulonephritis of NZB/W mice. J. Exp. Med. 127, 507-513.
83. Theofilopoulos, A. N., Dixon, F. J. (1985) Murine models of SLE. Adv. Immunol. 37, 269-285.
84. Dong, L., Ito, S., Ishii, K., Klinman, D. (2004) Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong the survival of lupus-prone NZB/W mice. Arthritis Rheum. 52, 651-658.
85. Alexander, C., Rietschel, E. T. (2001) Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7, 167-202.
86. Dobrovolskaia, M. A., Vogel, S. N. (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4, 903-914.
87. Akira, S., Takeda, K. (2004) Toll-like receptor signaling. Nat. Rev. Immunol. 4, 499-511. (in reference 10 "Yamamoto, Katoaka, Yano, Kuramoto, Shimada, Tokunaga, 1989").